http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20884059

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study
endingPage 152
issn 0165-5728
issueIdentifier 1-2
pageRange 145-152
publicationName Journal of Neuroimmunology
startingPage 145
bibliographicCitation Berger T, Jacobi C, Haas J, Ransmayr G, Guger M, Zettl UK, Di Pauli F, Taumberger B, Wietek S, Meuer S, Reindl M, Giese T. Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. J Neuroimmunol. 2014 Dec 15;277(1-2):145–52. doi: 10.1016/j.jneuroim.2014.10.001. PMID: 25454729.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15c5d39a2a534de9677dfad09bb73509
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_675ebc1c8eaeb27e58188019eab64426
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c30a04516e6760835c08980a6d09b0f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acabec18a5a8aa7fc422998c147853fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4410c2f71e2f03742d8ce8931a1baea9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73813bb0abc78490acbccef95cbe46d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b94b64e5da0c01f6aaacf3a20c91bd24
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0e7e0ded00568c91f867abc97a98eb3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2817-1402
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42bd3b7fc826c6769b0aa7764adfd00d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19dc5f84ddb0c6d63f4b79ea954b7e70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b11cad173c9005a57b3b2d54da03895
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d0f5de4dc83d420375a1bf4604267e1
date 2014-12-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/25454729
https://doi.org/10.1016/j.jneuroim.2014.10.001
isPartOf https://portal.issn.org/resource/ISSN/0165-5728
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4636
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics
discusses http://id.nlm.nih.gov/mesh/M0024747
http://id.nlm.nih.gov/mesh/M0025515
http://id.nlm.nih.gov/mesh/M0011157
http://id.nlm.nih.gov/mesh/M0019167
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020529Q000235
http://id.nlm.nih.gov/mesh/D020529Q000188
http://id.nlm.nih.gov/mesh/D016756Q000627
http://id.nlm.nih.gov/mesh/D007155Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010597
http://id.nlm.nih.gov/mesh/D016207Q000097
http://id.nlm.nih.gov/mesh/D012333Q000378
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D020641
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D004185
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005838
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D015203
http://id.nlm.nih.gov/mesh/D005434
http://id.nlm.nih.gov/mesh/D020529Q000473

Showing number of triples: 1 to 51 of 51.